rTMS depression

rTMS depression and other psychiatric conditions.

When pulses are applied repeatedly rTMS (repetitive transcranial magnetic stimulation—rTMS), they are thought to induce long-lasting neuroplastic effects, proposed to be a therapeutic mechanism for rTMS, with efficacy and safety initially demonstrated for treatment-resistant depression (TRD). Since then, many rTMS treatment protocols emerged for other difficult to treat psychiatric conditions. Moreover, multiple clinical studies, including large multi-center trials and several meta-analyses, have confirmed its clinical efficacy in different neuropsychiatric disorders, resulting in evidence-based guidelines and recommendations. This article below focuses on the approval of rTMS for psychiatric disorders. Please follow the link below the headline of the article below.

Regulatory Clearance and Approval of Therapeutic Protocols of Transcranial Magnetic Stimulation for Psychiatric Disorders


by Goncalo Cotovio, Fabiana Ventura, Daniel Rodrigues da Silva, Patricia Pereira, Albino J. Oliveira-Maia,

Champalimaud Research and Clinical Centre, Champalimaud Foundation, 1400-038 Lisbon, Portugal2
NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade NOVA de Lisboa, 1169-056 Lisbon, Portugal3
Departamento de Psiquiatria e Saúde Mental, Centro Hospitalar de Lisboa Ocidental, 1449-005 Lisbon, Portugal4
Departamento de Psiquiatria e Saúde Mental, Centro Hospitalar e Universitário de Coimbra, 3000-075 Coimbra, Portugal5
Portuguese Red Cross Health School, 1300-125 Lisbon, Portugal*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.

Related Posts